Cataract Removal Clinical Trials

Clinical trials related to Cataract Removal Procedure

EVALUATION OF MILOOP LENS FRAGMENTATION DEVICE IN PHACOEMULSIFICATION FOR DENSE CATARACTS: A RANDOMIZED CONTROLLED TRIAL

Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to find out if using the miLOOP device during cataract surgery confers additional protection against cornea (endothelial) cells loss by reducing the amount of ultrasound energy needed. It will also look at how well patients see after surgery and how safe the procedure is. The main questions it aims to answer are: * Does the miLOOP device reduce the loss of corneal endothelial cells during and after cataract surgery? * Does it reduce the amount of ultrasound energy used to remove dense cataracts? * Are vision and safety outcomes better with the miLOOP compared to standard surgery? Researchers will compare cataract surgery using the miLOOP device to standard cataract surgery without the device. Participants with dense cataracts will: * Be randomly assigned to have cataract surgery via conventional method or the miLOOP-assisted method * Attend follow-up visits to check vision, eye cell health, and any problems after surgery

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• age 40-year-old and above

• capable to give informed consent

• Advanced visually significant cataract with a minimum grade 4 nuclear sclerosis based on Lens Opacities Classification System III (LOCS III)

• Best corrected visual acuity of 6/18 or worse using Snellen visual acuity chart

• Willingness to cooperate with the doctors in the follow-up visits

Locations
Other Locations
Malaysia
Hospital Canselor Tuanku Muhriz
RECRUITING
Cheras
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 68
Treatments
Active_comparator: MiLOOP-assisted nucleus fragmentation
Participants in the miLOOP-assisted phacoemulsification group will receive miLOOP assisted lens fragmentation prior to the commencement of phacoemulsification.
Active_comparator: Conventional phacofragmentation using 'Stop-and-chop' technique
For standard phacoemulsification group, the stop-and-chop technique will be deployed for lens nucleus disassembly.
Related Therapeutic Areas
Sponsors
Leads: Universiti Kebangsaan Malaysia Medical Centre

This content was sourced from clinicaltrials.gov